A major advance in cancer research is arising with the use of mini-antibodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently lost in various types of cancer, leading uncontrolled https://doctorbookmark.com/story22009941/vhh-fragments-revive-the-p53-protein-new-promising-pathway-for-tumor-therapy